Index by author

September 1, 2021; Volume 62,Issue 9

  1. Pacak, Karel

    1. Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697

  2. Packard, Annie T.

    1. Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
      Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048

  3. Papin, Caroline

    1. Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
      Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008

  4. Pattison, David

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659

  5. Pavlakis, Nick

    1. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
      David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659

  6. Pienta, Kenneth J.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226

  7. Pomper, Martin G.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226

  8. Prasad, Vikas

    1. PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?
      Winfried Brenner, Joachim Strobel and Vikas Prasad
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1242-1243; DOI: https://doi.org/10.2967/jnumed.121.262737

  9. Prive, Bastiaan M.

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541

  10. Pryma, Daniel A.

    1. Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
      Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697
Back to top

In this issue